Rank #1326MDGL

Madrigal Pharmaceuticals, Inc.

$436.87

-11.11% (Daily)

Market Cap

$9.92B

Revenue

$740.64M

Rank by MCap

#1326

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. William J. Sibold

Headquarters

West Conshohocken, PA

Employees

528

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.